Tandem Diabetes Care, Inc. (TNDM)

59.54 3.42%
02:53 pm EDT; Powered by IEX
Pros
Revenue growth higher than the industry and sector averages
Company’s profitability is improving
Forward PEG ratio low relative to industry peers
Buy analyst rating
Average analyst stock price above current stock price
Cons
Forward P/E ratio high relative to industry peers
Forward P/B ratio high relative to industry peers
High short share of float
High short interest

Pros

  1. TNDM quarterly revenue growth was 24.90%, higher than the industry and sector average revenue growth (11.23% and 7.51%, respectively). See TNDM revenue growth chart.
  2. TNDM profitability is improving. The YoY profit margin change was 31.18 percentage points. See TNDM profitability chart.
  3. TNDM PEG ratio (P/E adjusted for growth) is 0.31, which is low compared to its industry peers’ PEG ratios. See TNDM PEG chart.
  4. TNDM average analyst rating is Buy. See TNDM analyst rating chart.
  5. TNDM average analyst price target ($130.00) is above its current price ($65.26). See TNDM price target chart.

Cons

  1. TNDM forward P/E ratio is 88.28, which is high compared to its industry peers’ P/E ratios. See TNDM forward P/E ratio chart.
  2. TNDM Price/Book ratio is 10.78, which is high compared to its industry peers’ P/B ratios. See TNDM forward Price/Book ratio chart.
  3. TNDM short share of float is 6.18%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See TNDM short share of float chart.
  4. TNDM short interest (days to cover the shorts) ratio is 7.85. The stock garners more short interest than the average industry, sector or S&P 500 stock. See TNDM short interest ratio chart.